Viera Lukáčová
- Molecular Biology
- Oncology top 10%
- Pharmaceutical Science top 2%
- Computational Theory and Mathematics top 5%
- Pharmacology top 5%
- Co-authors
- Štefan BalážMichael B. BolgerWalter S. WoltoszSoumyendu RahaDaniel M. KrollAkash KhandelwalNeil ParrottAki T. Heikkinen
- Topics
- Drug Transport and Resistance Mechanisms (13 papers)Pharmaceutical studies and practices (10 papers)Pharmacogenetics and Drug Metabolism (8 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Viera Lukáčová
52 papers receiving 936 citations
Peers
Comparison fields: 5 of 118
- Molecular Biology 371
- Oncology 234
- Pharmaceutical Science 184
- Computational Theory and Mathematics 173
- Pharmacology 149
Countries citing papers authored by Viera Lukáčová
This map shows the geographic impact of Viera Lukáčová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viera Lukáčová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viera Lukáčová more than expected).
Fields of papers citing papers by Viera Lukáčová
This network shows the impact of papers produced by Viera Lukáčová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viera Lukáčová. The network helps show where Viera Lukáčová may publish in the future.
Co-authorship network of co-authors of Viera Lukáčová
This figure shows the co-authorship network connecting the top 25 collaborators of Viera Lukáčová. A scholar is included among the top collaborators of Viera Lukáčová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viera Lukáčová. Viera Lukáčová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 6 | |
| 10 | 1 | |
| 11 | 24 | |
| 12 | 2 | |
| 13 | 10 | |
| 14 | 16 | |
| 15 | 94 | |
| 16 | 54 | |
| 17 | Modeling Drug Disposition in Ocular Tissues following Topical Eye Drops and Intravitreal Injection | 1 |
| 18 | 9 | |
| 19 | 14 | |
| 20 | 53 |
About Viera Lukáčová
Viera Lukáčová is a scholar working on Pharmaceutical Science, Pharmacology and Oncology, having authored 56 papers that have together received 951 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Pharmaceutical studies and practices (10 papers) and Pharmacogenetics and Drug Metabolism (8 papers). The work is most often cited by research in Pharmaceutical Science (184 citations), Pharmacology (149 citations) and Computational Theory and Mathematics (173 citations). Viera Lukáčová has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Štefan Baláž, Michael B. Bolger, Walter S. Woltosz, Soumyendu Raha, Daniel M. Kroll, Akash Khandelwal, Neil Parrott, Aki T. Heikkinen, Micaela B. Reddy and Alexander A. Vinks. Their work appears in journals such as Journal of Biological Chemistry, Langmuir and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.